Trastuzumab vs Vernakalant

## Trastuzumab vs Vernakalant: Overview

This comparison examines the pharmacological differences between **Trastuzumab** and **Vernakalant**.

## Mechanism of Action

**Trastuzumab**: Anti-HER2 monoclonal antibody inhibiting receptor signaling.

## Pharmacokinetics

**Half-life**: Trastuzumab — 28 days; Vernakalant — N/A.

## Chemical Properties

**Type**: Trastuzumab — Antibody; Vernakalant — Small molecule.